-
-
-
-
-
-
-
working groups
-
-
-
-
-
-
-
-
-
Massimo Terzolo, MD
Head of Department of Internal Medicine I
University of Torino
Regione Gonzole 10
Torino, Italy
Period in office: 2019-2025
Dr Judith FAVIER
Research Director, Head of the Genetics and Metabolism of Rare Cancers Laboratory, INSERM U970 – Paris-Cardiovascular Research Centre of the Georges Pompidou Hospital (HEGP), University Paris, Paris, France
Judith
Favier was trained as a molecular and cellular biologist as a PhD at
the Collège de France (Paris) and a post-doctoral fellow at the Montreal
Heart Institute (Canada), during which she studied the role of HIF2a in
angiogenesis. Since, her main research interest has been the study of
the genetics and the biology of pheochromocytomas and paragangliomas
with a particular focus on SDHB-mutated
tumors. She holds a Research Director position in the French National
Institute of Health and Medical Research (INSERM) and leads the team “Genetics and Metabolism of Rare Cancers” at the PARCC-HEGP. She
is the Co-Chairman of the «Animals models» working group of the
Pheochromocytoma Research Support Organization (PRESSOR) and was the
previous co-chair of PRESSOR (2015-2018). She is an Associate Editor at
the Endocrine-related Cancer journal.
Period in office as Head of PPGL WG and treasurer: 2021-2024
Marcus Quinkler, MD
Berlin, Germany
Marcus Quinkler is Professor of Internal Medicine and Endocrinology and consultant in the endocrine outpatient center “Endocrinology in Charlottenburg” in Berlin, Germany.
His clinical research focus includes adrenal physiology and pathophysiology, endocrine hypertension, pituitary disease, and mineralocorticoid and glucocorticoid action.
Professor Quinkler is a member of the Endocrine Society, European Society of Endocrinology and European Network of the study of adrenal tumors. He was speaker of the German Adrenal section of the DGE (German Endocrine Society), and is associated faculty member of the Charité University Medicine Berlin, Germany.period in office: 2021-2024
Marta Araujo-Castro, Madrid, Spain
period in office: 2022-2026Cristina Ronchi MD, PhD, FRCP, DSc
Institute of Metabolism and Systems Research (IMSR)
University of Birmingham
& Centre for Endocrinology, Diabetes and Metabolism (CEDAM)
Birmingham Health Partners
Birmingham, UK
& Department of Endocrinology and Diabetes
University Hospital of Wuerzburg
Wuerzburg (Germany)
Dr Cristina L Ronchi is Reader in Endocrine Oncology at the Institute of Metabolism and Systems Research (University of Birmingham, UK). She is also Consultant Endocrinologist at the Queen Elizabeth Hospital Birmingham, where she serves as the Lead of the Adrenal Tumour Specialist Service. Her current research field focuses on the molecular pathogenesis of adrenocortical tumours and Cushing syndrome as well as novel prognostic markers for patients with adrenocortical cancer.
Dr Ronchi is a member of many national and international societies, is on the editorial board of several international journals and coordinated multiple studies on behalf of the ENS@T.
period in office: 2021-2024
period in office: 2019-2022